A ball milling-based approach to depolymerize polyester biopolymers (PLA, PHAs) into value-added monomers and chemicals via solvent-free alcoholysis, enabling efficient recycling of mixed plastic films with reduced energy and solvent requirements.
This research proposes a mechanochemical approach to depolymerize polyester biopolymers such as polylactic acid (PLA) and polyhydroxyalkanoates (PHAs) into value-added chemicals and monomers. By using ball milling instead of traditional solution-based alcoholysis, the process eliminates the need for large volumes of solvent and high temperatures while accelerating reaction kinetics. The technology is designed to handle mixed polyester films, addressing a key challenge in plastic recycling where heterogeneous feedstocks are difficult to process efficiently.
The value proposition centers on enabling energy-efficient, solvent-free depolymerization that can convert biopolymer waste streams into separable, value-added products such as cyclic lactones and acyclic esters. Differences in boiling points among these products allow for facile downstream separation, making the approach attractive for industrial-scale chemical recovery and circular economy initiatives.
Core technology:
Key process parameters:
Analytical capabilities:
This research is at an early-to-mid stage of development. The underlying ball milling expertise and mechanistic understanding of radical polymerizations are already established in the laboratory. The proposed work will validate the hypothesis that mechanochemistry can effectively depolymerize mixed polyester films into separable value-added chemicals. The project is planned as a one-year study focused on establishing relationships between polymer composition, alcohol selection, Lewis acid catalysis, and product distribution. The laboratory is seeking industrial partnership for materials, perspective, and funding for personnel and supplies to advance toward broader validation and potential scale-up.
The University of Washington is a large public research university with campuses in Seattle, Bothell, and Tacoma, known for a broad portfolio from fundamental discovery to applied innovation. Industry partners engage through a South Lake Union research campus adjacent to a major life sciences district and through collaboration programs that place faculty and students alongside corporate R&D. The university’s integration with a major academic health system enables clinical translation and large-scale trials. Research is supported by competitive federal funding from NIH, NSF, DOE, and DoD. A dedicated technology transfer office manages IP, licensing, and startup incubation with prototyping resources.